SOURCE: WayPoint Biomedical, Inc.

June 12, 2006 09:13 ET

WayPoint's Drink Detective™ Drink Spiking Test Kit and Awareness Program Gains Acceptance and Repeat Sales in the College Community

HUNTINGTON BEACH, CA -- (MARKET WIRE) -- June 12, 2006 -- WayPoint Biomedical, Inc. (PINKSHEETS: WYPH) sees increasing acceptance and repeat sales of their Drink Detective™ Test Kit in conjunction with WayPoint's Drink Spiking Education and Awareness Program into the college community.

According to WayPoint Biomedical president, Bret Hendzel, "With the recent introduction of our new '2-Test Kit Awareness Pack,' we are seeing an increase in sales, particularly in the college community. The new pack contains two test kits, a tri-fold information brochure and a credit card sized Safe Drinking Tip card." Hendzel adds, "We are now seeing various college alumni, helpline, rape crisis and support groups purchasing significant quantities of the product and support literature, then implementing Drink Spiking and Date-Rape Awareness/Education Programs in conjunction with distributing test kits to their students. Several top-tier college support groups, including groups from Columbia University, MIT, Boston University and the University of Colorado are implementing programs to help educate their students and protect them from the increasing danger of rape, robbery and even death due to drink spiking perpetrated crimes."

The Drink Detective™ is an easy to use, rapid test kit that can detect the presence of over 60 date rape drugs in seconds. Drink Detective™ kits are credit card sized, to remain discreet, and include a dropper for administering the test on 3 separate strips that test for different drugs. The drugs identified by the kit include gamma hydroxybuturate (GHB), ketamine (Special K), and more than 60 drugs in the benzodiazepine group, such as Rohypnol®, Valium®, Xanax® and Clonopin®.

About WayPoint Biomedical, Inc.

WayPoint Biomedical, Inc., a wholly owned subsidiary of WayPoint Biomedical Holdings, Inc. (PINKSHEETS: WYPH), is an innovative biomedical technology firm, specializing in diagnostic tests and devices for screening and monitoring human health, fitness and environment. The Company develops and markets cutting-edge disposable rapid tests that offer both a preliminary diagnostic screen to specific conditions, along with a future path for consumers, medical providers, and first responders to follow regarding their health status or environmental condition. For more information on WayPoint Biomedical visit,

Forward-Looking Statements

This press release contains forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially.

Contact Information